Asset Details
Do you wish to reserve the book?
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
Do you wish to request the book?
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
2015
Overview
In this trial, patients with atrial fibrillation who required warfarin interruption for an elective procedure were assigned to either bridging anticoagulation or placebo. Forgoing bridging was noninferior to bridging for arterial thromboembolism and superior for major bleeding.
For patients with atrial fibrillation who are receiving warfarin and require an elective operation or other elective invasive procedure, the need for bridging anticoagulation during perioperative interruption of warfarin treatment has long been uncertain.
1
–
3
Each year, this common clinical scenario affects approximately one in six warfarin-treated patients with atrial fibrillation.
4
,
5
Warfarin treatment is typically stopped 5 days before an elective procedure to allow its anticoagulant effect to wane; it is resumed after the procedure, when hemostasis is secured, at which point 5 to 10 days of treatment is required to attain therapeutic anticoagulation.
6
,
7
During the interruption of . . .
Publisher
Massachusetts Medical Society
Subject
/ Anticoagulants - administration & dosage
/ Anticoagulants - adverse effects
/ Atrial Fibrillation - drug therapy
/ Bleeding
/ Elective Surgical Procedures
/ Embolism
/ Female
/ Hemorrhage - chemically induced
/ Heparin
/ Heparin, Low-Molecular-Weight - administration & dosage
/ Heparin, Low-Molecular-Weight - adverse effects
/ Humans
/ Ischemia
/ Male
/ Patients
/ Postoperative Complications - prevention & control
/ Stroke
/ Surgery
/ Thromboembolism - prevention & control
/ Warfarin
